Tower Research Capital (TRC)’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-50
| Closed | – | – | 6619 |
|
|
2023
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 6618 |
|
|
2022
Q4 | $0 | Buy |
+50
| New | +$21 | ﹤0.01% | 6696 |
|
|
2022
Q1 | – | Sell |
-2,293
| Closed | -$19K | – | 6909 |
|
|
2021
Q4 | $19K | Buy |
+2,293
| New | +$26.9K | ﹤0.01% | 3762 |
|
|
2021
Q2 | – | Sell |
-5,012
| Closed | -$45K | – | 6037 |
|
|
2021
Q1 | $45K | Buy |
5,012
+4,574
| +1,044% | +$33.4K | ﹤0.01% | 3225 |
|
|
2020
Q4 | $2K | Sell |
438
-3,084
| -88% | -$13.6K | ﹤0.01% | 4942 |
|
|
2020
Q3 | $12K | Buy |
3,522
+3,296
| +1,458% | +$11K | ﹤0.01% | 4044 |
|
|
2020
Q2 | $0 | Buy |
226
+35
| +18% | +$106 | ﹤0.01% | 5087 |
|
|
2020
Q1 | $0 | Sell |
191
-109
| -36% | -$499 | ﹤0.01% | 4180 |
|
|
2019
Q4 | $1K | Buy |
+300
| New | +$1.41K | ﹤0.01% | 3367 |
|
|
2018
Q2 | – | Sell |
-660
| Closed | -$2K | – | 4210 |
|
|
2018
Q1 | $2K | Buy |
+660
| New | +$4.18K | ﹤0.01% | 2994 |
|
|
2017
Q4 | – | Sell |
-746
| Closed | -$5K | – | 4189 |
|
|
2017
Q3 | $5K | Sell |
746
-5
| -0.7% | -$32 | ﹤0.01% | 3344 |
|
|
2017
Q2 | $5K | Sell |
751
-1,742
| -70% | -$12.7K | ﹤0.01% | 2033 |
|
|
2017
Q1 | $26K | Buy |
2,493
+808
| +48% | +$8.79K | ﹤0.01% | 1127 |
|
|
2016
Q4 | $21K | Buy |
1,685
+1,643
| +3,912% | +$60.4K | ﹤0.01% | 2102 |
|
|
2016
Q3 | $4K | Buy |
42
+4
| +11% | +$390 | ﹤0.01% | 2743 |
|
|
2016
Q2 | $3K | Sell |
38
-6
| -14% | -$520 | ﹤0.01% | 3767 |
|
|
2016
Q1 | $3K | Sell |
44
-183
| -81% | -$11.6K | ﹤0.01% | 3193 |
|
|
2015
Q4 | $21K | Buy |
227
+138
| +155% | +$13.2K | ﹤0.01% | 1260 |
|
|
2015
Q3 | $10K | Buy |
+89
| New | +$10.2K | ﹤0.01% | 2326 |
|
|
2015
Q2 | – | Sell |
-25
| Closed | -$3K | – | 5207 |
|
|
2015
Q1 | $3K | Sell |
25
-50
| -67% | -$5.12K | ﹤0.01% | 3622 |
|
|
2014
Q4 | $7K | Buy |
75
+50
| +200% | +$4.26K | ﹤0.01% | 2489 |
|
|
2014
Q3 | $2K | Sell |
25
-200
| -89% | -$15.3K | ﹤0.01% | 3904 |
|
|
2014
Q2 | $17K | Sell |
225
-71
| -24% | -$5.52K | ﹤0.01% | 1947 |
|
|
2014
Q1 | $24K | Buy |
+296
| New | +$27.1K | ﹤0.01% | 1722 |
|
Other funds holding PLXP
Tower Research Capital (TRC)'s PLXP Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 50 shares.
Tower Research Capital (TRC) first reported a position in PLXP in Q1 2014 and held it in 24 quarters. The position peaked at $45K in Q1 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 50 PLx Pharma Inc. Common Stock shares in Q2 2023.
- Tower Research Capital (TRC) first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 24 quarters.
- Tower Research Capital (TRC)'s PLx Pharma Inc. Common Stock position peaked at $45K in Q1 2021.
- 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.